Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer
Nicosia, Cyprus, Dec. 09, 2020 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to…
News
Novartis Kisqali® data demonstrate superior benefit across main intrinsic subtypes in metastatic breast cancer
Findings presented at SABCS from largest intrinsic subtype analysis show Kisqali is unique among CDK4/6…
Pfizer and BioNTech Achieve Health Canada Authorization for Their Vaccine to Combat COVID-19
Health Canada authorizes supply of COVID-19 mRNA vaccine under Interim Order Respecting the Importation, Sale…
CohBar Confirms Efficacy of Novel Apelin Agonists in Acute Respiratory Distress Syndrome (ARDS) Model
MENLO PARK, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 58 / 2020 Copenhagen, December 9, 2020 – Zealand Pharma A/S…
Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer
MONALEESA-7 median overall survival (OS) results reinforce Kisqali as the CDK4/6 inhibitor with unrivaled OS…
Arcutis Highlights Advanced Pipeline & Unique Immuno-Dermatology Drug Development Capabilities at Virtual Investor Day on December 9, 2020
Broad and deep portfolio of highly differentiated product candidates aligned with needs of patients and…
Telo Genomics Presents at ASH 2020 The Results of Hodgkin’s Lymphoma Clinical Study
TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Telo Genomics Corp. (TSX-V: TELO) (the “Company” or…
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trials for STI-2020 (COVI-AMG) in Healthy Volunteers and in Newly Diagnosed COVID-19 Patients
FDA has granted clearance for the commencement of Phase 1 clinical trials of STI-2020 (COVI-AMGTM)…
Amunix Presents Preclinical Data on AMX-818, a Protease-Activated HER2-Targeted T Cell Engager Prodrug, at SABCS 2020
– Data demonstrate potential of Amunix’s XPAT (XTENylated Protease–Activated T cell engager) platform to mitigate…